Company intelligence / Profile preview
Ozone Pharmaceuticals Ltd
- Ownership
- Private
- Development stage
- Commercial
Overview
Ozone Pharmaceuticals Ltd. manufactures and markets a wide range of generic medicines for chronic and acute conditions including cardiovascular disease, diabetes, hyperlipidemia and respiratory illnesses. The company operates two modern manufacturing facilities in India and distributes its products nationally. No clinical trial data or novel drug development programs are publicly reported.
- Therapeutic areas
- CardiovascularEndocrinologyInfectious Diseases
- Modalities
- Small molecules (tablets, syrups)
- Industry
- Biotech
Drug pipeline
7 assets6 more assets in the full pipeline.
Beyond the preview
Go deeper on Ozone Pharmaceuticals Ltd.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Ozone Pharmaceuticals Ltd.